DuPont de Nemours, Inc. · NYSE:DD
DuPont de Nemours — DuPont — Q2 2013 Earnings Presentation
30 slides from DuPont de Nemours's earnings presentation, Jul 23, 2013
Slide 1: DuPont 2Q 2013 Earnings Conference Call
DuPont 2Q 2013 Earnings Conference Call July 23, 2013 1
Slide 2: Regulation G, Forward Looking Statements, Developing Markets
Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the company and
Slide 3: 2Q 2013 Financial Highlights
2Q 2013 Financial Highlights $ in billions, except EPS 2Q13 vs. 2Q12 YTD13 vs. ‘12 EPS Operating earnings* $1.28 (15)% $2.84 (10)% GAAP earnings $1.10 $2.58 Segment Operating Earnings* $1.9 (17)% $4.1 (12)% Consolidated Net Sales $9.8 (1)% $20.3 1% Volume 1% 2% Local Prices (1)% 0% Currency Impact (
Slide 4: Global Sales – Regional Highlights
Global Sales – Regional Highlights 2Q 2013 Sales by Region 2Q 2013 Sales YOY % CHG Region % Latin America 9% Worldwide (1) Developed Asia U.S. & Canada 8% U.S. & Canada 1 49% Non-U.S. & Canada (2) Developing Asia Developing Markets 1 13% Developing Asia (5)* Developed Developing Developing EMEA 6 EM
Slide 5: 2Q 2013 Segment Operating Earnings Variance
2Q 2013 Segment Operating Earnings* Variance $14 $1 ($330) ($44) ($9) ($8) ($6) ($4) $2,225** $1,839** 2Q12 Other IB Perf Chem N&H S&P Perf Mtls Ag E&C 2Q13 Key Lower Perf Chem earnings largely due to Ti02 price declines N&H and Ag results impacted by cool, wet spring and higher input costs Take
Slide 6: 2Q 2013 Operating EPS Variance
2Q 2013 Operating EPS* Variance ($0.31) $0.02 $0.02 $0.03 $0.02 $1.50 $1.28 2Q12 EPS Segment results EGL Corp exp Lower shares Other 2Q13 EPS Lower Perf Chem results were primary driver for EPS decline Key Segment results include a ($.03) currency impact Takeaways Restructuring savings deliver
Slide 7: Balance Sheet and Cash
Balance Sheet and Cash June 30, 2013 Free Cash Flow Free Cash Flow* YTD12 YTD13 • Increase in seasonal FCF outflow due to 0.0 lower cash earnings and higher Ag working -1.0 $ Billions capital, partially offset by lower pension -2.0 contributions • Capex spend: $0.8B YTD13; ~$1.9B FY -3.0 -4.0 Strong
Slide 8: Next Steps in the Transformation of DuPont
Next Steps in the Transformation of DuPont To A Higher Growth, Higher Value Company • Realignment of Senior Leaders • Exploring Strategic Alternatives for Performance Chemicals Redesigned Performance Danisco Cost Structure Coatings Acquisition $2 billion lower Divestiture Aligned With Strategic Plan
Slide 9: Integrated Science - the Growth Engine of DuPont
Integrated Science - the Growth Engine of DuPont Particle & Inorganic / Gene Metabolic Recombination Dispersion Organic Engineering Science Fluoro Synthesis & Regulation Chemical & Biochemistry Agronomy Genomics Polymer Synthesis Rheology Nutrition Cell / Tissue Catalysis Control Science Culture Pol
Slide 10: Three Strategic Priorities
Strategic Plan to Increase the Value of DuPont Generate Superior Shareholder Returns by Building and Leveraging World-Leading Positions Across Three Attractive Spaces Bio-based Advanced Ag & Nutrition Industrials Materials Extend our leadership across the Develop world-leading high-value, science-dr
Slide 11: APPENDIX – Segment Results
APPENDIX – Segment Results The segment slides that follow and related commentary on second quarter 2013 segment results can be found on the Earnings News Release link on the Investor Center website at www.dupont.com 11
Slide 12: Agriculture
Agriculture Pioneer, Crop Protection 2Q Sales * 2Q and 1H Comments 5.0 2Q Sales +7%, operating earnings 1% lower 4.0 Higher seed input costs pressured margins $ in Billions 3.0 Accelerated pace of corn seed sales in 1Q 1H sales +11%, operating earnings +8% 2.0 1H seed sales up 11% on prici
Slide 13: Electronics & Communications
Electronics & Communications 2Q Sales * 2Q Comments 1.0 Sales down 18%, primarily on lower sales into PV 0.8 Lower silver prices contributed to reduced top $ in Billions 0.6 line sales 0.4 Operating earnings down $4 million on lower sales 0.2 2Q13 operating earnings included $20 million 0.0
Slide 14: Industrial Biosciences
Industrial Biosciences 2Q Sales * 2Q Comments 0.4 Sales 1% higher on higher price 0.3 Strong demand and higher prices for Sorona® in $ in Billions carpeting were offset by lower enzyme volumes 0.2 for ethanol and animal nutrition 0.1 Operating earnings were up 2% as sales growth was partially
Slide 15: Nutrition & Health
Nutrition & Health 2Q Sales * 2Q Comments 1.0 Sales 2% lower with higher prices offset by unfavorable 0.8 currency, lower enablers volume and the impact of $ in Billions manufacturing site closures 0.6 Lower enablers volume due to market softness in Europe and 0.4 Asia and unseasonably cool weat
Slide 16: Performance Chemicals
Performance Chemicals Titanium Technologies (DTT), Chemicals & Fluoroproducts (DC&F) 2Q Sales * 2Q Comments Sales down 9% primarily from lower Ti02 prices 2.0 Ti02 volumes up 12% YoY, 18% sequentially $ in Billions 1.5 Volume gains in fluoropolymers more than offset by 1.0 lower demand and pri
Slide 17: Performance Materials
Performance Materials Performance Polymers (DPP), Packaging & Industrial Polymers (P&IP) 2Q Sales * 2Q Comments 2.0 Sales down 2% with slightly lower prices partially offset by higher packaging volumes $ in Billions Automotive demand mixed with Europe, Japan and 1.6 Korea weakness offset by stre
Slide 18: Safety & Protection
Safety & Protection Protection Technologies (DPT), Building Innovations (BI), Sustainable Solutions (DSS) 2Q Sales * 2Q Comments 1.2 1.0 Sales up 3% on higher volumes, partially offset by unfavorable currency and prices $ in Billions 0.8 0.6 Higher volume primarily reflects increased demand for
Slide 19: The miracles of science
The miracles of science” 19
Slide 20: DuPont Second Quarter 2013 Earnings Segment Commentary
DuPont Second Quarter 2013 Earnings Segment Commentary This data should be read in conjunction with the Company’s second quarter earnings news release dated July 23, 2013 and DuPont 2Q2013 Earnings Conference Call presentation materials posted on the Investor Center website at www.dupont.com. 1
Slide 21: Agriculture
Agriculture Pioneer, Crop Protection 2Q Sales * 2Q and 1H Comments 5.0 2Q Sales +7%, operating earnings 1% lower 4.0 Higher seed input costs pressured margins $ in Billions 3.0 Accelerated pace of corn seed sales in 1Q 1H sales +11%, operating earnings +8% 2.0 1H seed sales up 11% on prici
Slide 22: Pioneer Field360 Select launch commentary
In the 2nd quarter, we launched our next generation services offering, Pioneer®Field360™ Select software, to which we continue to add functionality that growers value. As a leader in precision farming services, we provide crop analytics on more than 10 million customer acres annually, and this sprin
Slide 23: Corn share gains and crop protection commentary
corn share gain in each of the past summer and safrinha seasons, and we are seeing rapid adoption of hybrids with Optimum® Intrasect® insect control protection. Also, our insect control portfolio, led by Rynaxypyr®, continues to perform well, and we are planning wider-scale testing of our Lumigen® s
Slide 24: Electronics & Communications
Electronics & Communications 2Q Sales * 2Q Comments 1.0 Sales down 18%, primarily on lower sales into PV 0.8 Lower silver prices contributed to reduced top $ in Billions 0.6 line sales 0.4 Operating earnings down $4 million on lower sales 0.2 2Q13 operating earnings included $20 million 0.0
Slide 25: Industrial Biosciences
Industrial Biosciences 2Q Sales * 2Q Comments 0.4 Sales 1% higher on higher price 0.3 Strong demand and higher prices for Sorona® in $ in Billions carpeting were offset by lower enzyme volumes 0.2 for ethanol and animal nutrition 0.1 Operating earnings were up 2% as sales growth was partially
Slide 26: Nutrition & Health
Nutrition & Health 2Q Sales * 2Q Comments 1.0 Sales 2% lower with higher prices offset by unfavorable 0.8 currency, lower enablers volume and the impact of manufacturing site closures $ in Billions 0.6 Lower enablers volume due to market softness in Europe and 0.4 Asia and unseasonably cool weat
Slide 27: Performance Chemicals
Performance Chemicals Titanium Technologies (DTT), Chemicals & Fluoroproducts (DC&F) 2Q Sales * 2Q Comments Sales down 9% primarily from lower Ti02 prices 2.0 Ti02 volumes up 12% YoY, 18% sequentially $ in Billions 1.5 Volume gains in fluoropolymers more than offset by 1.0 lower demand and pri
Slide 28: Performance Materials
Performance Materials Performance Polymers (DPP), Packaging & Industrial Polymers (P&IP) 2Q Sales * 2Q Comments 2.0 Sales down 2% with slightly lower prices partially offset by higher packaging volumes $ in Billions Automotive demand mixed with Europe, Japan and 1.6 Korea weakness offset by stre
Slide 29: Safety & Protection
Safety & Protection Protection Technologies (DPT), Building Innovations (BI), Sustainable Solutions (DSS) 2Q Sales * 2Q Comments 1.2 1.0 Sales up 3% on higher volumes, partially offset by unfavorable currency and prices $ in Billions 0.8 0.6 Higher volume primarily reflects increased demand for
Slide 30: Non-GAAP and Forward-Looking Statements notes
other companies. Reconciliations of non-GAAP measures to GAAP are provided in schedules A, C and D to the Company’s second quarter 2013 Earnings News Release, available on the Investor Center website at http://www.dupont.com. Forward-Looking Statements: This news release contains forward-looking sta